The acceleration of pharma’s digital transformationFrom this summer’s vantage point 2019 seems like it was at least a decade ago, such is the Share XThe acceleration of pharma’s digital transformationhttps://pharmaphorum.com/digital/the-acceleration-of-pharmas-digital-transformation/
Novartis, company culture and COVID-19: the pharmaphorum podcastNovartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face Share XNovartis, company culture and COVID-19: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-company-culture-covid-19/
Next wave: how pharma analytics can be improved with new technologiesPharmaceutical companies have always had access to a steady stream of data to look at what has happened Share XNext wave: how pharma analytics can be improved with new technologieshttps://pharmaphorum.com/views-and-analysis/next-wave-how-pharma-analytics-can-be-improved-with-new-technologies/
Brits more comfortable sharing data with pharma since COVID-19 – surveyNew research from MHP Health and ComRes looks at what impacts COVID-19 has had on the public’s health Share XBrits more comfortable sharing data with pharma since COVID-19 – surveyhttps://pharmaphorum.com/views-and-analysis/brits-data-sharing-pharma-covid-19-survey/
Country focus: Iraq’s pharma industry sees upward trajectoryAfter decades of turmoil, Iraq’s healthcare sector is growing fast – but the country still holds some unique Share XCountry focus: Iraq’s pharma industry sees upward trajectoryhttps://pharmaphorum.com/views-analysis-market-access/country-focus-iraq-pharma-industry/
GSK’s John Fleming on rethinking oncology from the ground upWhat if we could look at cancer treatment from a completely fresh perspective? This is the philosophy GSK’s Share XGSK’s John Fleming on rethinking oncology from the ground uphttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/gsks-john-fleming-on-rethinking-oncology-from-the-ground-up/
Coronavirus pharma news roundup – 24/07/20With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie Share XCoronavirus pharma news roundup – 24/07/20https://pharmaphorum.com/views-analysis-market-access/coronavirus-pharma-news-roundup-24-07-20/
How modular content provides ‘light-speed’ review and boosts engagementTwenty-first century communications are fast, personalised and multi-channel – all of which can seem diametrically opposed to the Share XHow modular content provides ‘light-speed’ review and boosts engagementhttps://pharmaphorum.com/views-analysis-sales-marketing/how-modular-content-provides-light-speed-review-and-boosts-engagement/
MSD’s David Peacock on moving UK healthcare forwardDavid Peacock has worked across the world for MSD and other companies, and has now taken the helm Share XMSD’s David Peacock on moving UK healthcare forwardhttps://pharmaphorum.com/views-analysis-sales-marketing/msds-david-peacock-on-moving-uk-healthcare-forward/
